[ad_1]
The government agreed on Wednesday to buy 620,000 from BioNTech and Pfizer. additional doses of vaccine and 10,000. extra doses of Moderns. In Lithuania, preparations developed by both companies are used.
The purchase of 185 thousand is also planned. Additional doses of Valneva have not yet been approved in Europe.
Following this decision, Lithuania plans to acquire more than 3.7 million. Pfizer, more than 500 thousand. “Modern” and about 370 thousand. Valneva vaccine dose.
The European Union has already signed contracts with six companies: AstraZeneca, Johnson & Johnson, Sanofi and GSK, Pfizer and BioNTech, CureVac and Moderna. Of these, Lithuania plans to acquire more than 10 million. doses of vaccines.
So far, the European Medicines Agency (EMA) has approved three vaccines: Pfizer and BioNTech, and Moderna and AstraZeneca.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
